![]() |
Volumn 413, Issue 2, 1997, Pages 265-268
|
The use of recombinant vaccinia virus to generate monoclonal antibodies against the cell-surface glycoprotein endoglin
|
Author keywords
Endoglin (human); Monoclonal antibody; Surface antigen; Vaccinia virus
|
Indexed keywords
COMPLEMENTARY DNA;
ENDOGLIN;
GLYCOPROTEIN;
MONOCLONAL ANTIBODY;
POLYCLONAL ANTIBODY;
THYMIDINE KINASE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANTIBODY PRODUCTION;
ARTICLE;
CELL FUSION;
CHICKEN;
CONTROLLED STUDY;
DRUG CROSS REACTIVITY;
GENE INSERTION;
HUMAN;
HYBRIDOMA;
IMMUNE RESPONSE;
MOLECULAR CLONING;
MOUSE;
MYELOMA CELL;
NONHUMAN;
PRIORITY JOURNAL;
SPECIES DIFFERENCE;
SPLEEN CELL;
TECHNIQUE;
VACCINIA VIRUS;
VIRUS INFECTION;
VIRUS RECOMBINANT;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIBODY SPECIFICITY;
ANTIGENS, CD;
HUMANS;
HYBRIDOMAS;
MICE;
MICE, INBRED BALB C;
RECEPTORS, CELL SURFACE;
RECOMBINANT FUSION PROTEINS;
THYMIDINE KINASE;
VACCINIA;
VACCINIA VIRUS;
VASCULAR CELL ADHESION MOLECULE-1;
ANIMALIA;
GALLUS GALLUS;
VACCINIA;
VACCINIA VIRUS;
|
EID: 18344415741
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-5793(97)00860-0 Document Type: Article |
Times cited : (8)
|
References (16)
|